Sun Pharma stock has gained 5.88 per cent in a year and fallen 2.29 percent in 2023. A total of 0.52 lakh shares of the firm changed hands amounting to a turnover of Rs 5.08 crore on BSE.
Shares of Sun Pharma fell over 4 per cent today after the firm reported weak earnings for the quarter ended March 2022. The firm reported a consolidated net loss of Rs 2,277 crore in the last quarter, on account of a one-time exceptional loss.
Shares of Sun Pharma fell over 4 per cent today after the firm said the US FDA issued 10 observations for its Halol Plant. The stock slipped 4.41 per cent to Rs 846.35 against the previous close of Rs 885.35 on BSE. The stock has fallen after two days of consecutive gain. Shares of Sun Pharma trade higher than 200-day moving averages but lower than 5-day, 20-day, 50-day, and 100-day moving averages. Sun Pharma stock has gained 23.18 per cent in a year and risen 1.73 percent in 2022.